The above investigations show that while EGFR mutations have a strong correlation with IL-6 expression in a portion of lung cancer patients, there are many other known (TGFβ, for example) and unkonwn factors contributing to IL-6 expression upregulation. This evidence concerns the gene IL6 and lung cancer.